Abstract |
D2A21, a novel peptide antibiotic has in vitro activity against a wide spectrum of sexually transmitted diseases (STD). In this study we tested the hypothesis that intravaginal D2A21 would interfere with acquisition of Trichomonas vaginalis infection in a modified mouse model. T. vaginalis infections of estrogenized young mice pretreated with Lactobacillus vaginalis or Lactobacillus rhamnosus were more frequent and persistent than those in mice pre-treated with Lactobacillus gasseri or Lactobacillus acidophilus. One hundred percent T. vaginalis infection was achieved for 2-4 days post-challenge when intravaginal L. rhamnosus pre-treatments were given to estrogenized mice 48 hr prior to a single T. vaginalis challenge. Estrogenized mice pre-treated with L. rhamnosus were pre-medicated with intravaginal placebo gel, 0.5% or 2% D2A21 gel, or 500 microg/mL metronidazole gel prior to T. vaginalis challenge. Both 2% D2A21 and metronidazole gels were significantly more efficacious (10% or none infected) than placebo gel (53% infected) in preventing vaginal T. vaginalis infections in mice.
|
Authors | W B Lushbaugh, A C Blossom, P H Shah, A K Banga, J M Jaynes, J D Cleary, R W Finley |
Journal | The American journal of tropical medicine and hygiene
(Am J Trop Med Hyg)
2000 Nov-Dec
Vol. 63
Issue 5-6
Pg. 284-9
ISSN: 0002-9637 [Print] United States |
PMID | 11421379
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Anti-Bacterial Agents
- Antimicrobial Cationic Peptides
- D2A21
- Estrogens
- Gels
- Peptides
- Metronidazole
|
Topics |
- Administration, Intravaginal
- Animals
- Anti-Bacterial Agents
(administration & dosage, pharmacology)
- Antimicrobial Cationic Peptides
- Disease Models, Animal
- Estrogens
- Female
- Gels
- Lactobacillus
- Metronidazole
(administration & dosage, pharmacology)
- Mice
- Mice, Inbred BALB C
- Peptides
- Trichomonas Vaginitis
(prevention & control)
- Trichomonas vaginalis
(drug effects)
|